391 related articles for article (PubMed ID: 26683792)
1. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
Lampropoulou E; Lymperopoulou A; Charonis A
Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
[TBL] [Abstract][Full Text] [Related]
2. ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells.
Alberti A; Karamessinis P; Peroulis M; Kypreou K; Kavvadas P; Pagakis S; Politis PK; Charonis A
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E812-21. PubMed ID: 19622788
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway.
Wang L; Liu Y; Yang J; Zhao H; Ke J; Tian Q; Zhang L; Wen J; Wei R; Hong T
Endocrinology; 2014 Oct; 155(10):3817-28. PubMed ID: 25051441
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
Tamura K; Minami K; Kudo M; Iemoto K; Takahashi H; Seino S
PLoS One; 2015; 10(5):e0126003. PubMed ID: 25938469
[TBL] [Abstract][Full Text] [Related]
5. Role of ERp46 in β-cell lipoapoptosis through endoplasmic reticulum stress pathway as well as the protective effect of exendin-4.
Chen DL; Xiang JN; Yang LY
Biochem Biophys Res Commun; 2012 Sep; 426(3):324-9. PubMed ID: 22935416
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
7. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
Shimoda M; Kanda Y; Hamamoto S; Tawaramoto K; Hashiramoto M; Matsuki M; Kaku K
Diabetologia; 2011 May; 54(5):1098-108. PubMed ID: 21340625
[TBL] [Abstract][Full Text] [Related]
8. beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL
Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
[TBL] [Abstract][Full Text] [Related]
9. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
10. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
Moffett RC; Patterson S; Irwin N; Flatt PR
Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
[TBL] [Abstract][Full Text] [Related]
11. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
Li Y; Zheng J; Shen Y; Li W; Liu M; Wang J; Zhu S; Wu M
Med Sci Monit; 2018 May; 24():3293-3300. PubMed ID: 29777582
[TBL] [Abstract][Full Text] [Related]
12. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
[TBL] [Abstract][Full Text] [Related]
13. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
Hao T; Zhang H; Li S; Tian H
Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
16. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M
Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262
[TBL] [Abstract][Full Text] [Related]
17. IRE1-XBP1 pathway regulates oxidative proinsulin folding in pancreatic β cells.
Tsuchiya Y; Saito M; Kadokura H; Miyazaki JI; Tashiro F; Imagawa Y; Iwawaki T; Kohno K
J Cell Biol; 2018 Apr; 217(4):1287-1301. PubMed ID: 29507125
[TBL] [Abstract][Full Text] [Related]
18. Effect of Liraglutide on endoplasmic reticulum stress in diabetes.
Zhao L; Guo H; Chen H; Petersen RB; Zheng L; Peng A; Huang K
Biochem Biophys Res Commun; 2013 Nov; 441(1):133-8. PubMed ID: 24129189
[TBL] [Abstract][Full Text] [Related]
19. Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes.
Mihailidou C; Chatzistamou I; Papavassiliou AG; Kiaris H
Pflugers Arch; 2016 Nov; 468(11-12):1957-1968. PubMed ID: 27757583
[TBL] [Abstract][Full Text] [Related]
20. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
